LAFRX
Price
$21.81
Change
-$0.30 (-1.36%)
Updated
Jun 5 closing price
Net Assets
6.71B
RMFEX
Price
$62.34
Change
-$0.71 (-1.13%)
Updated
Jun 5 closing price
Net Assets
114.65B
Interact to see
Advertisement

LAFRX vs RMFEX

Header iconLAFRX vs RMFEX Comparison
Open Charts LAFRX vs RMFEXBanner chart's image
LAFRX vs RMFEX Comparison Chart in %
View a ticker or compare two or three
VS
LAFRX vs. RMFEX commentary
Jun 07, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LAFRX is a Buy and RMFEX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RMFEX has more cash in the bank: 115B vs. LAFRX (6.71B). RMFEX pays higher dividends than LAFRX: RMFEX (1.45) vs LAFRX (0.72). LAFRX was incepted earlier than RMFEX: LAFRX (19 years) vs RMFEX (24 years). LAFRX (0.94) is less costly to investors than RMFEX (0.62). LAFRX is a more actively managed with annual turnover of: 50.00 vs. RMFEX (30.00). LAFRX has a lower initial minimum investment than RMFEX: LAFRX (0) vs RMFEX (250). LAFRX annual gain was more profitable for investors over the last year : 14.13 vs. RMFEX (9.76). RMFEX return over 5 years is better than : 34.94 vs. LAFRX (28.97).
LAFRXRMFEXLAFRX / RMFEX
Total Expense Ratio0.940.62152%
Annual Report Gross Expense Ratio0.940.62152%
Fund Existence19 years24 years-
Gain YTD9.1335.682161%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets6.71B115B6%
Annual Yield % from dividends0.721.4550%
Returns for 1 year14.139.76145%
Returns for 3 years49.6635.82139%
Returns for 5 years28.9734.9483%
Returns for 10 years63.8097.4465%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AI10.43-0.15
-1.42%
C3ai
ANOHX26.96-0.92
-3.30%
American Century Small Cap Growth G
CNTY1.40-0.05
-3.45%
Century Casinos
ST49.84-2.80
-5.32%
Sensata Technologies Holding plc
NMRA1.63-0.12
-6.86%
Neumora Therapeutics